Patient preferences for symptom-driven or regular preventer treatment in mild to moderate asthma: findings from the PRACTICAL study, a randomised clinical trial

Christina Baggott, Helen K. Reddel, Jo Hardy, Jenny Sparks, Mark Holliday, Andrew Corin, Barney Montgomery, Jim Reid, Davitt Sheahan, Robert J. Hancox, Mark Weatherall, Richard Beasley, James Fingleton

Source: Eur Respir J, 55 (4) 1902073; 10.1183/13993003.02073-2019
Journal Issue: April
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Christina Baggott, Helen K. Reddel, Jo Hardy, Jenny Sparks, Mark Holliday, Andrew Corin, Barney Montgomery, Jim Reid, Davitt Sheahan, Robert J. Hancox, Mark Weatherall, Richard Beasley, James Fingleton. Patient preferences for symptom-driven or regular preventer treatment in mild to moderate asthma: findings from the PRACTICAL study, a randomised clinical trial. Eur Respir J, 55 (4) 1902073; 10.1183/13993003.02073-2019

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Self-titration of inhaled corticosteroid and ß2-agonist in response to symptoms in mild asthma: a pre-specified analysis from the PRACTICAL randomised controlled trial
Source: Eur Respir J, 56 (4) 2000170; 10.1183/13993003.00170-2020
Year: 2020



A randomized controlled trial on office spirometry in asthma and COPD in standard general practice: the SPACE Italian study
Source: Eur Respir J 2005; 26: Suppl. 49, 670s
Year: 2005

Clinical effectiveness of self-management of asthma in general practice: a randomized controlled trial
Source: Eur Respir J 2001; 18: Suppl. 33, 518s
Year: 2001

A randomised clinical trial of feedback on inhaler adherence and technique in patients with severe uncontrolled asthma
Source: Eur Respir J, 51 (1) 1701126; 10.1183/13993003.01126-2017
Year: 2018



Efficacy and safety of once-daily low-dose indacaterol/mometasone via Breezhaler® in symptomatic adult and adolescent patients with inadequately controlled asthma: Phase III randomised QUARTZ study findings
Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Asthma
Year: 2019




Morphine for refractory breathlessness in COPD: a randomized clinical intervention study
Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD
Year: 2020


The Children's Anti-inflammatory Reliever (CARE) study: a protocol for a randomised controlled trial of budesonide-formoterol as sole reliever therapy in children with mild asthma
Source: ERJ Open Res, 7 (4) 00271-2021; 10.1183/23120541.00271-2021
Year: 2021



The ARIETTA study: baseline demographics in a real-world setting in patients with severe asthma
Source: International Congress 2017 – Bronchial asthma management
Year: 2017


Stop omalizumab: a multicenter follow up study after discontinuation in pediatric patients with severe asthma
Source: Virtual Congress 2021 – Paediatric allergic asthma: novel therapeutics and monitoring approaches
Year: 2021


Effectiveness of a pharmacist intervention for asthma control improvement: randomised controlled trial
Source: Annual Congress 2007 - Delivering respiratory care: the challenges for primary care
Year: 2007


Cost-effectiveness of self-management in asthmatics: a 1-yr follow-up randomized, controlled trial
Source: Eur Respir J 2001; 17: 206-213
Year: 2001



The coping with asthma study: a randomised controlled trial and economic evaluation of a home-based nurse intervention for adults at risk of adverse asthma outcomes
Source: Eur Respir J 2003; 22: Suppl. 45, 536s
Year: 2003

Effect of tele healthcare on quality of life in patients with severe COPD: a randomized clinical trial
Source: International Congress 2017 – Best abstracts in physical activity and management of COPD
Year: 2017

Efficacy and safety of isoproterenol continuous inhalation treatment for acute severe exacerbation of asthma in children; a randomized, double-blind controlled study
Source: International Congress 2015 – Paediatric asthma and allergy: asthma management
Year: 2015


Run-in bias in randomised trials: the case of COPD medications
Source: Eur Respir J, 49 (6) 1700361; 10.1183/13993003.00361-2017
Year: 2017



Towards optimal patient selection for bronchial thermoplasty treatment in severe asthma: results from the TASMA randomized trial
Source: International Congress 2019 – Clinical studies of asthma treatments
Year: 2019


Effectiveness of a pharmacist-led inhalation technique intervention on asthma and COPD patients: The INspira cluster-randomized controlled trial
Source: Virtual Congress 2021 – Highlights for primary care in 2021
Year: 2021



Top-10 comorbidities of symptomatic patients with moderate COPD in the clinical setting of the CRYSTAL study
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016


A non-interventional observational trial to study the COPD treatment choices in routine clinical practice in Bulgaria
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016


Late Breaking Abstract - Can a self-management plan, which includes a four-fold increase in inhaled corticosteroid dose, reduce severe asthma exacerbations: a randomised, pragmatic trial.
Source: International Congress 2017 – Late-breaking findings in asthma and COPD
Year: 2017